Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
75 results about "Disease progress" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Disease progression. A change in the way an illness affects a patient as it moves from its earliest stages to its peak and then to its resolution.
Multi-format, multi-domain and multi-algorithm metalearner system and method for monitoring human health, and deriving health status and trajectory
InactiveUS20170249434A1Effective therapyAccurate trackingDigital data information retrievalTelemedicinePersonalizationDisease monitoring
Real-time and individualized disease monitoring is central to rapidly evolving medical sciences and technologies, but for the vast majority of patients, disease progression and treatment are monitored only in an irregular and discontinuous fashion. Consequently, disease progression and relapse are often allowed to proceed too far before they are detected, compromising the possibility of any effective treatment. For one patient, this can mean becoming refractory to the few early drug treatments that are available; for another, missing early detection may be deadly. This invention provides a method for the detection of early signals of disease and recovery thereof comprising a universal yet personalized health-monitoring solution using cell phones or other wearable smart device data that generate extensive real-time data. The invention further provides a system and method to provide answers to a variety of questions related to the patient health status and health trajectory. Its flexibility and generality is designed for a preferred application to rare disorders and rare questions for which other analytical system are lacking.
Owner:EARLY SIGNAL LLC
Information processing method for disease stratification and assessment of disease progressing
InactiveUS20040243362A1Reducing time spent repetitivelyFailure can be accuratelyMedical simulationMedical data miningInformation processingOptimal treatment
A digital computer system stratifies in a set of patients, based on a set of observations. The observations can include physical, biochemical, histological, genetic, and gene-expression data, among other types of information. Adjustments can be made to account for the possibility that observations of several patients may begin at different points in the progression of their respective disease processes. Once these adjustments are made, the data are subjected to a statistical cluster analysis. Each cluster of patients potentially represents a different disease stratum, with its own underlying cause, optimum therapy, and prognosis. Once the strata are defined and patients are assigned to them, adjustments to the data can be refined. The cluster analysis then can be repeated, and so an iterative process of stratification and staging takes place.
Owner:PROSANOS CORP
Quantification and visualization of the motion and deformation of one or several objects inside a living entity
The invention relates to the quantitative analysis and / or visualization of the relative motion of objects in particular of the relative motion of one or several objects inside a living entity, for instance the human body or a living cell. The invented system and method allow to quantify and visualize the motion of these objects with respect to the parts of the living entity, which can deform and move itself with respect to each other. Furthermore, the method allows to identify movements and deformations which correspond to situations with a particular meaning for the living entity, for instance predicting complications in a disease progress, etc. An important application is the analysis of motion and deformation of stent-grafts introduced after endovascular repair of aneurysms. Here, the occurrence of deformations leading to graft-limb occlusions and of migrations of the stent-graft leading to so-called endoleaks can be predicted in an early stage. This allows an early intervention, hence, avoiding more severe problems. The motion is calculated from pairs of images corresponding to different points in time using semi-automatic steps to extract point sets (or binary images) and an automatic procedure to determine the motion and deformation of the point sets and to describe it quantitatively. An important part of the method is the visualization allowing the user to have an immediate impression of the occurring movements and deformations.
Owner:MATTES JULIAN +4
Information processing apparatus and information processing method
This invention is directed to appropriately searching for case data similar in the process of a disease. A similar case search apparatus (100) according to this invention includes a disease progress model building function of building a disease progress model by extracting feature amounts from a plurality of medical images obtained by imaging the same object in different periods, a unit configured to read out case data, a unit configured to acquire inspection data, a similar case search function of interpolating, by using the model, feature amounts extracted from the plurality of medical images contained in the inspection data, and calculate a similarity between the inspection data and the case data by using the interpolated feature amounts, and a monitor (111) which displays case data selected based on the calculated similarity.
Owner:CANON KK
Soft robotic assistive gripping device
ActiveUS20180361596A1Easy to controlEasy to removeProgramme-controlled manipulatorGripping headsDiseaseEngineering
This invention is directed to offer a customizable, cost effective, and comfortable soft gripping solution for patients with chronic disabilities, such as diabetic neuropathy, allowing the patients to function independently and perform routine daily tasks. A soft robotic gripper has been developed with one or more inflatable systems actuated by aft to assist a user to grip an object. The main body of the gripper bends with air actuation while the fingertip actuation helps functionality in the extremities. The gripper is further enhanced by adding sensors that integrate feedback for sensitivity to touch, conformability, and grip ability. The modular design modifications allow for gripper adjustments as the disease progresses or rescinds. The gripper also works as a training aid for routine physical therapy exercises. Data collected by a microprocessor can also help learn more about these chronic diseases and use artificial intelligence to customize treatment regimens for individual patients.
Owner:BERI ALEKH RAJESH
Identity authentication system and method of electronic medical record system
InactiveCN103116869AAvoid security issuesAvoid readingData processing applicationsPublic key for secure communicationMedical recordPhysician attending
The invention discloses an identity authentication system and a method of an electronic medical record system. Identity information and electronic signature information (private key) of users are stored in a negative feedback circuit (NFC) of an intelligent mobile phone. The users are capable of reading the identity information which is stored in the NFC of the intelligent mobile phone from a terminal of the electronic medical record system, entering into the electronic medical record system, and obtaining the relevant work authorization (a resident doctor, an attending physician, a botanic physician, a nurse and a regulator), carrying out work like writing advices of the doctors, writing down medical records, recording the disease progress, executing and checking the advices of the doctors, examining and verifying the medical records and the like. After finishing recording, users can carry out an electronic signature by utilizing the private key in the NFC of the mobile phone. Due to the fact that the phones can be portable, if the users go away, the phones are taken away; the system can automatically log off the system. Logging and signing of the electronic medical records are safe and simple, and the method is worthy of popularizing.
Owner:JIANGSU PROVINCE HOSPITAL +1
New applications of antibody of GDF15 (Growth differentiation factor 15) protein
ActiveCN101852804AMicrobiological testing/measurementImmunoglobulins against growth factorsSerodiagnosesDisease
The invention discloses new applications of an antibody of GDF15 (Growth differentiation factor 15) protein. The invention provides the following three applications of the antibody of the GDF15 protein: 1. the application in preparing a reagent for assisting to identify a hepatitis C patient or a hepatitis B patient; 2. the application in preparing a reagent kit for assisting to identify the hepatitis C patient or the hepatitis B patient; and 3. the application in preparing a reagent kit for assisting to identify the hepatitis C progress of the hepatitis C patient, wherein the hepatitis C progress is chronic hepatitis C, hepatitis C cirrhosis or liver cancer. On the basis of the three applications, the antibody of the GDF15 protein can be prepared into three reagent kits. The reagent kit can be used for the serological diagnosis of viral hepatitis (the hepatitis C or the hepatitis B) and judging the disease progress (the chronic hepatitis C, the hepatitis C cirrhosis or the liver cancer) and for prognosis and viral hepatitis treatment monitoring and has great value for the diagnosis and the treatment of the hepatitis C and the hepatitis B.
Owner:INST OF PATHOGEN BIOLOGY CHINESE ACADEMY OF MEDICAL SCI
Progression Inhibitor For Disease Attributed To Abnormal Accumulation Of Liver Fat
The present invention provides pharmaceutical compositions useful as agents for the inhibition of progression of diseases associated with abnormal accumulation of liver lipids. In particular, the pharmaceutical compositions of the present invention which comprise as an active ingredient a sodium / glucose co-transporter 2 inhibitor are highly suitable as an agent for the inhibition of progression of not only common fatty liver but also non-alcholic fatty liver disease (NAFL), non-alcholic steatohepatitis (NASH), hypernutritive fatty liver, diabetic fatty liver, alcholic fatty liver disease toxic fatty liver or the like.
Owner:KISSEI PHARMA
Treatment of autoimmune disorders using detoxified cobratoxin
InactiveUS20080254137A1Good effectDigestive systemMuscular disorderAutoimmune responsesWidespread Disease
Autoimmune disorders are widespread diseases with many manifestations. Immune regulatory dysfunction is central to the progress of these diseases. The control this dysfunction can be achieved through intervention in the immune pathways. The balance of regulatory cytokines is central to a correctly functioning immune system and is a target for therapeutic intervention. Herein is described the induction of the regulatory cytokines, interferon gamma and interleuking 27, as a method to treat autoimmune diseases and a method by which such regulatory cytokines can be induced using a detoxified cobra neurotoxin composition.
Owner:RECEPTOPHARM
Therapy for neurological diseases
The present invention relates to compositions and methods for treating neurological diseases in a subject. More specifically, the invention relates to combination therapies for treating such diseases, using a c-kit inhibitor and a neuroactive compound. The invention may be used against a variety of demyelinating diseases, including multiple sclerosis, in any mammalian subject, particularly human subjects, and at various stages of disease progression.
Owner:ARES TRADING SA
Bactericide composition containing fluoride ether bacteria amide and laminarin
ActiveCN104012535ASynergistic effect is obviousLower resistanceBiocideFungicidesPhytophthora sp.Cotton red
The invention relates to a bactericide composition containing fluoride ether bacteria amide and laminarin. The bactericide composition comprises a suspending agent, wettable powder, water dispersible granules and the like prepared from the fluoride ether bacteria amide, the laminarin and auxiliary agents including a wetting dispersant, a filling agent and the like. An experiment research shows that the fluoride ether bacteria amide and the laminarin are mixed according to a ratio from (10:1) to (50:1); a systemic fungicide is combined with a disease-resistant inducing agent so that the bactericide composition has an obvious synergistic effect on cucumber downy mildew, and can also delay a disease progress; the dosage of the chemical pesticide fluoride ether bacteria amide is reduced and the resistance to the fluoride ether bacteria amide by pathogenic bacteria can be effectively delayed. The bactericide composition is suitable for preventing and treating many vegetable oomycete diseases including the cucumber downy mildew, tomato phytophthora diseases, phytophthora capsici, potato late blight and the like, and can also be used for preventing and treating cotton seedling stage diseases including cotton red rot diseases and the like.
Owner:SHANDONG COTTON RES CENT
Chinese medicinal composition for treating leukemia
InactiveCN102363023AImprove the quality of lifeInduced transformationUnknown materialsAntineoplastic agentsPatriniaCancer cell
The invention relates to a Chinese medicinal composition for treating leukemia. The Chinese medicinal composition is prepared from the following Chinese medicines: rubia cordifolia, sophora flavescens, almond, dahurian patrinia herb, natural indigo, turtle shell, zedoary, angelica sinensis, astragalus, codonopsis pilosula, bitter orange, manyflower solomonseal rhizome, arillus longan, glossy privet fruit, epimedium herb, dried rehmannia glutinosa, fructus psoraleae, caulis spatholobi, Japanese knotweed and liquorice. The Chinese medicinal composition for treating leukemia is prepared by the conventional decoction preparation method, all medicines are combined, and restrain and support each other, so kidney yin is nourished, healthy energy is supported, foul secretion is eliminated, pathogenic toxin is removed, the immunologic function is improved obviously, cancer cells are induced to be transformed into normal cells, and disease progress can be effectively controlled or relieved and the survival quality of a patient is improved while a human body is not damaged.
Owner:宋世昌
New application of human urine kininogenase and medicine composition comprising same
ActiveCN104940914ADelay disease progressionRestore memoryNervous disorderPeptide/protein ingredientsDiseasePentoxyfylline
The invention belongs to the field of medicine, and particularly relates to a new application of human urine kininogenase and a medicine composition comprising the human urine kininogenase. The human urine kininogenase is applied to prepare medicine for treating the Alzheimer's disease. The invention further provides the medicine composition for treating the Alzheimer's disease. The medicine composition comprises the human urine kininogenase and bilobalide, and further comprises pentoxifyline. The medicine composition can remarkably recover the memory capacity of a patient suffering with the Alzheimer's disease, improve the cognition capacity of the patient suffering with the Alzheimer's disease, delay the disease progress of the Alzheimer's disease, greatly improve the life quality of the patient suffering with the Alzheimer's disease, improve the treatment compliance of the Alzheimer's disease, improve the treatment effect, provide the effective treatment medicine for the patient suffering with the Alzheimer's disease, and greatly relieve pain of the patient of the Alzheimer's disease.
Owner:GUANGDONG TECHPOOL BIO-PHARMA CO LTD
Marker for predicting light-to-severe progression of COVID-19 patient, kit and establishment method
ActiveCN112837822ATimely forecastQuick forecastComponent separationEpidemiological alert systemsIntensive care medicineMedical treatment
The invention discloses a marker for rapidly predicting whether a COVID-19 patient suffers from light-to-severe progression or not, a kit thereof and an establishment method of the marker. According to the method, the severity of the condition of an early-stage COVID-19 patient is predicted through proteomics data, then potential critical patients are screened, and specific analysis can be carried out only by obtaining the three feature data of OAF, MB and DDT of the patient when the patient is admitted to hospital. The marker and the detection kit can timely, rapidly, objectively and accurately predict the severity of the condition of a COVID-19 patient and whether the disease progresses from light to severe, and assist medical staff in timely finding potential critical patients to allocate enough medical resources and attention, which are advantages that a traditional evaluation mode does not have. Therefore, the invention has great clinical application value for early rapid prediction and screening of the potential critical patients of COVID-19.
Owner:GUANGZHOU CENT FOR DISEASE CONTROL & PREVENTION (GUANGZHOU HYGIENE INSPECTION CENT GUANGZHOU CENT FOR FOOD SAFETY RISK SURVEILLANCE & ASSESSMENT INST OF PUBLIC HEALTH OF GUANGZHOU MEDICAL UNIV)
Nerve specificity olefinic alcohol enzyme chemiluminescence immune analysis determination reagent kit and preparing method thereof
ActiveCN101377499AHigh sensitivityRapid clinical diagnosisChemiluminescene/bioluminescenceAntigenDisease
The invention relates to the medical field of immunoassay, more specially, the invention provides a chemiluminescent immunoassay detection kit for nerve specific enolase and a preparation method thereof. The kit of the invention comprises 1) nerve specific enolase calibrators, 2) solid-phase vectors which are coated by nerve specific enolase monoclonal antibodies, 3) nerve specific enolase monoclonal antibody antigens which are marked by enzyme and 4) chemiluminescent substrates which are acted by the enzyme. The invention also provides a preparation method of the kit, which comprises the steps: preparing the calibrators, coating the vectors, marking the antibodies, packaging, and the like. The kit of the invention has the advantages of convenience, rapidness, sensitivity, stability, and the like. The invention can provide good technical support for the early detection, the detection of disease progress and the judgment of healing effect of some diseases such as small cell lung carcinoma (SCLC), neuroblastoma, brain damage, and the like.
Owner:CHEMCLIN DIAGNOSTICS CO LTD
Tetrapeptide with function of resisting Abeta protein aggregation and application of tetrapeptide as well as gene for encoding tetrapeptide
InactiveCN108676065AImprove medical conditionDelay disease progressionNervous disorderTetrapeptide ingredientsCell AggregationsProtein aggregation
The invention provides a tetrapeptide with a function of resisting Abeta42 protein aggregation and application of the tetrapeptide as well as a gene for encoding the tetrapeptide. The synthetic peptide has the efficacy of obviously resisting the Abeta42 protein aggregation, and further has the effects of improving memory and delaying disease progress of Alzheimer's disease; the synthetic peptide can be widely applied to preparation of a medicine or food for resisting the Abeta42 protein aggregation, or is applied to preparation of a medicine or food for preventing or treating the Alzheimer's disease, and can further effectively prevent and treat neurodegenerative diseases including AD disease so as to improve medical conditions of the neurodegenerative diseases; the tetrapeptide has greatsocial and economic benefits.
Owner:SOUTH CHINA UNIV OF TECH
Chinese herbal preparation for treating ankylosing spondylitis
InactiveCN102091137BElimination of microcondensationInhibit or repair damageAnthropod material medical ingredientsAntipyreticMedicinal herbsHerbal preparations
Owner:王殿玲
Traditional Chinese medicinal composition for brightening and spot-removing and preparation method of preparation
InactiveCN103223151AImprove barrier propertiesPromote absorptionAnthropod material medical ingredientsDermatological disorderDiseaseSide effect
The invention relates to a traditional Chinese medicinal composition for brightening and spot-removing and a preparation method of the preparation. Raw components of the traditional Chinese medicinal composition comprise: by weight, 25-35 parts of pseudostellaria root, 10-20 parts of Cyperus Rotundus L, 6-10 parts of scorpion, 8-12 parts of muscardine silkworm, 15-25 parts of Poria cocos, 15-25 parts of dahurian angelica root, 25-35 parts of radix paeoniae rubrathe, 15-25 parts of Chinese angelica, 15-25 parts of cynanchi root, 8-12 parts of folium callicarpae pedunculalae, 25-35 parts of Ligusticum wallichii, 25-35 parts of motherwort, 10-20 parts of szechwan Chinaberry fruit, 20-30 parts of Artemisia anomala and 20-30 parts of ginger juice. The preparation method comprises the following steps: mixing, crushing, adding 75% ethanol and carrying out reflux extraction for 2-3 times, merging filtrates, concentrating to obtain a thick extract, and drying to obtain pulvis. The traditional Chinese medicinal composition has advantages of comprehensive conditioning specific to cause of disease, fast pharmaceutical effectiveness and little side effect, can be used to achieve the purpose of internal and external treatment combination and simultaneous treatment of principal and subordinate symptoms, inhibit disease progresses, make skin to be recovered to former levels and obviously shorten course of disease, has obvious treatment effects, and is worth popularizing and applying.
Owner:赛珏生物科技(河北)有限公司
Chronic disease recovery remote communication support system based on cyber physical system (CPS)
ActiveCN105847331AReduce error rateReduce missed detection rateTransmissionMedical recordSupporting system
The invention belongs to the technical field of communication, and discloses a chronic disease recovery remote communication support system based on a cyber physical system (CPS). The system comprises a doctor client, an administrator client, a patient client and a management controller. In the system, the CPS technology is applied in the interaction between a doctor and a patient suffering from a chronic disease, so that a close doctor-patient relationship can be established, and instructive suggestions can be given according to medical records and current conditions of the patient; the patient can record and store physical sign indexes, daily input and output volumes, laboratory test report photos and other information through the system, real-time dialogues can be carried out between the patient and the doctor, and interactive voice information regarding a disease progress can be converted into the medical records and medical orders. The system provided by the invention solves the problems of inaccurate information, a distant doctor-patient relationship, inconvenient registered treatments, high medical costs of the patient and the like in the conventional treatment process, can effectively detect and reduce the error rate and the examination omission rate of the interactive information, and can help the doctor and the patient to optimize treatment and rehabilitation effects.
Owner:BEIJING UNIV OF POSTS & TELECOMM
Chinese herbal preparation for treating ankylosing spondylitis
InactiveCN102091137AElimination of microcondensationInhibit or repair damageAnthropod material medical ingredientsAntipyreticMedicinal herbsDisease
The invention relates to a Chinese herbal preparation for treating ankylosing spondylitis, which comprises the following Chinese medicinal herbs by weight: 10g of rhizoma cibotii, 15g of pilose antler, 10g of himalayan teasel root, 5g of scorpio, 15g of kudzu vine root, 12g of chuanxiong rhizome, 5g of caulis spatholobi, 15g of white paeony root, 15g of common peony root, 10g of safflower carthamus, 15g of medicinal cyathula root and 10g of white mustard seed. The Chinese herbal preparation is prepared by using the steps of: weighing the Chinese medicinal herbs in the formula, adding 1500ml of water, decocting with slow fire to ensure that medicine liquid is concentrated to 250ml, filtering dregs of a decoction and preparing a decoction. During the treatment, the decoction is taken orally, each dosage is taken every day, and one treatment course includes 90 days. The Chinese herbal preparation is used for treating the ankylosing spondylitis through improving immunity and micro circulation and eliminating blood micro coagulation. The Chinese herbal preparation has the functions of inhabiting fibrosis and ossification, inhibiting or repairing bone destruction and the like, and achieves the purposes of releasing symptoms and inhibiting the disease progressing from multiple aspects and multiple links. The Chinese herbal preparation has the advantages of low cost and no toxic and side effects.
Owner:王殿玲
Heptapeptide with function of resisting Abeta protein aggregation and application of heptapeptide as well as gene for encoding polypeptide
ActiveCN108676071AImprove medical conditionDelay disease progressionNervous disorderPeptide/protein ingredientsCell AggregationsProtein aggregation
The invention discloses a heptapeptide with a function of resisting Abeta42 protein aggregation and application of the heptapeptide as well as a gene for encoding the polypeptide. The synthetic peptide has the efficacy of obviously resisting the Abeta42 protein aggregation, and further has the effects of improving memory and delaying disease progress of Alzheimer's disease; the synthetic peptide can be widely applied to preparation of a medicine or food for resisting the Abeta42 protein aggregation, or is applied to preparation of a medicine or food for preventing or treating the Alzheimer's disease, and can further effectively prevent and treat neurodegenerative diseases including AD disease so as to improve medical conditions of the neurodegenerative diseases; the heptapeptide has greatsocial and economic benefits.
Owner:SOUTH CHINA UNIV OF TECH
Alzheimer's disease progress prediction method
PendingCN113658721AEfficient use ofAvoid missingMedical data miningNeural architecturesMissing dataMedicine
The invention discloses an Alzheimer's disease progress prediction method, a patient is measured in a fixed time interval to obtain multi-view data, and the Alzheimer's disease progress prediction method comprises the following steps: preprocessing the multi-view data; processing the multi-view data by using a multi-view fusion neural network to obtain a hidden representation matrix shared by each view; introducing a minimum gating unit into the implicit representation matrix so as to fill missing multi-view data and predict score data of a future time point; and carrying out cooperative training on the multi-view fusion neural network and the minimum gating unit by using the multi-view data so as to predict the disease development process. According to the method, the hidden representation matrix shared among the views is obtained for the multi-view data of each time point through the multi-view fusion neural network, meanwhile, the data, obtained through prediction of the minimum gating unit, of the next time point is used for filling missing data, and score data prediction of any time point in the future is conducted through the minimum gating unit.
Owner:NANJING UNIV OF POSTS & TELECOMM
Traditional Chinese medicine preparation for treating rheumatic arthritis
The invention discloses a traditional Chinese medicine preparation for treating rheumatic arthritis. The traditional Chinese medicine preparation consists of following traditional Chinese medicine raw materials, by weight, common clubmoss, achyranthes bidentata, radix aconiti, kusnezoff monkshood roots, safflowers, frankincense, scorpions, musk, ground beetles, vernonia cumingiana, cassia twigs, fructus forsythiae, honeysuckle stems, gardenia and almonds. The traditional Chinese medicine preparation is prepared through dialectics on rheumatic arthritis in traditional Chinese medicine and several times of clinical formula compatibility. Through the traditional Chinese medicine preparation, a patient is enhanced in body immunity, is regulated and recovered in functions of liver, kidney, spleen and stomach, and is balanced in yin and yang through qi tonifying and blood boosting and wind dispelling and heat clearing, thereby diffusing and dissipating evils, warming and freeing channels and collaterals, expanding blood vessels, improving local blood circulation, promoting absorption of inflammation, enabling qi and blood to be sufficient, removing symptoms and curing the rheumatic arthritis. In addition, the traditional Chinese medicine preparation, through regulation of immune function in human body, can effectively inhibit disease status and improve health, can avoid relapse dangerousness caused by usage of hormones and can reduce episodes times and episodes serious degrees so that disease progress can be effectively stopped.
Owner:刘晓辉 +1
Klebsiella oxytoca for expressing luciferase and application of klebsiella oxytoca
InactiveCN110951764AEasy to operateImprove conversion efficiencyBacteriaMicrobiological testing/measurementDiseaseKlebsiella oxytoca
The invention constructs Klebsiella oxytoca containing luciferase gene cluster (luciferase gene cassette, lux) by utilizing plasmid construction and an electric transformation technology. Through autofluorescence identification, a subculture stability test of strains and observation of culture characteristics, the Klebsiella oxytoca (KOX-LUX) capable of stably expressing luciferase is finally obtained. An important visual research tool is provided for researching the progress of Klebsiella oxytoca related diseases and screening proper sterilization methods, antibiotics and the like.
Owner:BEIJING DITAN HOSPITAL CAPITAL MEDICAL UNIV
Therapeutic agent for ophthalmic disease
An agent for the prevention, treatment and / or inhibition of progression of an ophthalmic disease and an agent for the protection of an optic nerve, each of which comprises (2R)-2-propyloctanoic acid or a salt or prodrug thereof in which an amount per dose is from 0.3 ng to 5000 mg. The agents are useful for an ophthalmic disease, such as glaucoma, cataract, retinal detachment, muscae volitantes, age-related macular degeneration, diabetic retinopathy, macular edema, myopia, asthenopia, dry eye, amaurosis fugax, choked disc, papillitis optica, retrobulbar neuritis, toxic amblyopia, optic atrophy, higher visual pathway lesion, internuclear opthalmoplegia, gaze palsy and ischemic optic neuropathy.
Owner:ONO PHARMA CO LTD
Drug for stable stage of chronic obstructive pulmonary diseases and preparation method thereof
InactiveCN109939172AEnhance metabolic functionProtective structureUnknown materialsRespiratory disorderSnake gourdObstructive Pulmonary Diseases
The invention discloses a drug for a stable stage of chronic obstructive pulmonary diseases and a preparation method thereof. The medicinal effective components are composed of radix astragali preparata, sun-dried ginseng, bulbus Lily, cortex lycii, herba ephedrae preparata, semen armeniacae amarum, rhizoma atractylodis, gecko, bulbus fritillariae thunbergii, seeds of snake gourds, radix trichosanthis, poria cocos, dried orange peels, radix platycodi, rhizoma pinelliae preparata, radix glycyrrhizae preparata, rhizoma alismatis, cortex moutan and radix paeoniae rubra. The drug has the effects of tonifying deficiency (invigorating qi-yin of the lung and invigorating qi of the spleen and kidney), eliminating phlegm, removing dampness, facilitating diuresis, promoting blood circulation, removing blood stasis, nourishing yin, clearing away internal heat, ventilating the lung and unclogging the viscera. The drug can be used in the stable stage of chronic obstructive pulmonary diseases, improve immunity, reduce the frequency of acute aggravation induced by infection, improve the lung function, promote oxygenation, control the disease progress and relieve cough, expectoration, asthma, anddyspnea.
Owner:GUIYANG COLLEGE OF TRADITIONAL CHINESE MEDICINE
Liver-protecting traditional Chinese medicine health food
InactiveCN108066496AGood treatment effectReasonable processing technologyDigestive systemNatural extract food ingredientsGuidelineTaurine
The invention discloses liver-protecting traditional Chinese medicine health food. The liver-protecting traditional Chinese medicine health food is prepared from components in parts by weight as follows: 50-300 parts of herb of Penthorum chinense Pursh, 1-10 parts of folium ginkgo, 3-20 parts of radix paeoniae alba, 5-20 parts of tea polyphenol, 5-30 parts of radix astragali, 1-10 parts of radix glycyrrhizae, 1-10 parts of taurine and 1-15 parts of broccoli. The invention further discloses a preparation method of the liver-protecting traditional Chinese medicine health food. The liver-protecting traditional Chinese medicine health food and the preparation method have the following advantages: (1) traditional Chinese medicine theories are used as guidance and combined with modern pharmacological research results, physiological properties of the liver and characteristics of progress of liver diseases are considered fully, the treatment guidelines of removing dampness, descending turbid,nourishing the liver and the kidney, reinforcing qi, nourishing blood, activating blood and regulating qi are embodied, and the treatment and health care effects are quite good; (2) selected raw materials of the health food are food or articles which can be applied to the health food, the processing technology is reasonable, safety and effectiveness of the product are guaranteed, and the health food can be applied to liver protection and disease progress treatment of patients suffering from the liver diseases and can also be applied to prevention for people with liver injury trend.
Owner:威海紫光科技园有限公司
Molecular marker for diagnosing idiopathic inflammatory myopathy and application thereof
The invention relates to a molecular marker for diagnosing idiopathic inflammatory myopathy and an application thereof. The molecular marker is an autologous heat shock factor 1 (HSF1) antibody in a serum. The antibody is IgG. The idiopathic inflammatory myopathy is polymyositis (PM) or dermatomyositis (DM). The diagnosis is to distinguish the idiopathic inflammatory myopathy from a healthy population or to predict a disease progress of the idiopathic inflammatory myopathy (IIM).
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL
Progression inhibitor for disease attributed to abnormal accumulation of liver fat
InactiveUS20090286751A1Hindering progressSimple compositionBiocideMetabolism disorderDepressantBULK ACTIVE INGREDIENT
Owner:KISSEI PHARMA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com